Stifel Reiterates Buy Rating on Contineum Therapeutics (CTNM)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/28/2026
- Wall Street ends higher on revived AI momentum
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
| (NASDAQ: CTNM) | Delayed: 8.99 +0.85 (10.44%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.14 | 52 Week High | $ | |||
| Open | $8.18 | 52 Week Low | $ | |||
| Day High | $9.12 | P/E | N/A | |||
| Day Low | $8.02 | EPS | $ | |||
| Volume | 643,755 | |||||
